创伤后脑损伤神经精神病症状的管理
Tremearne Hotz1, Jackie Long1, Natalia Kosyakova1
1Department of Psychiatry, Institute of Living, 200 Retreat Avenue, Hartford, CT 06106, USA.
Clinics in sports medicine
|March 5, 2026
概括
在创伤性脑损伤 (TBI) 后管理神经精神症状是复杂的. 由于患者表现和受伤类型不同,个性化,多学科的治疗是必不可少的.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 康复医学 康复医学 康复医学
背景情况:
- 创伤性脑损伤 (TBI) 经常导致神经精神病症状.
- 识别和管理这些症状带来了持续的临床挑战.
研究的目的:
- 审查TBI后神经精神病症状的范围.
- 强调需要量身定制的治疗策略.
主要方法:
- 在TBI之后的神经精神病学后果的文献综述.
- 讨论当前和新兴的治疗方式.
主要成果:
- 在TBI后,可以出现各种各样的神经精神症状.
- 药理和非药理干预表明潜在的疗效.
结论:
- 患者的异质性和受伤机制需要个性化,多学科的护理.
- 多方面的治疗计划对于有效的TBI神经精神病症状管理至关重要.
更多相关视频
04:02Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024
1.6K
10:59Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury
Published on: November 19, 2012
15.9K
相关概念视频
Post-traumatic Stress Disorder
702
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
702
Psychosis: Goals of Pharmacotherapy
646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
